NASDAQ’s Recommendation: 3 Marijuana Stocks To Watch

Pictures of PotInsys also sells generic Dronabinol SG, a second-line cannabinoid drug used for chemotherapy-induced nausea and vomiting and anorexia associated with weight loss in patients with AIDS.

Dronabinol SG isn’t making a big financial impact for Insys, but the company does have two other marijuana-based drugs in development that could one day be winners.

First, Insys is in phase 2/3 clinical studies for Dronabinol Oral Solution, an orally administered liquid form of the drug that looks to be more effective than the capsule version.

Second, like GW Pharmaceuticals, Insys won FDA Orphan Drug Designation for its cannabidiol oral solution as a potential treatment for Dravet syndrome and Lennox-Gastaut syndrome.

To read more visit

Posted in: Investing

Comments are closed.